David Vaughn MD, MPH

David W. Vaughn, M.D., M.P.H. joined GSK Vaccines in 2007 with roles as the Clinical Lead for Pandemic Influenza Vaccines, Head of Global Vaccines Clinical Laboratories, Head of External R&D, North America, and currently as the Senior Vaccine Development Leader for Influenza and Dengue Vaccines also working in support of GSK’s proposal to establish a Biopreparedness Organization.

This follows a 21-year career with the U.S. Army where he served as the Chief of the Department of Pediatrics in Nurnberg, Germany, Chief of the Department of Virology at the Armed Forces Research of Medical Sciences in Bangkok, Thailand and the Chief of the Department of Virus Diseases, Walter Reed Army Institute of Research leading efforts to develop vaccines against dengue, Japanese encephalitis, hepatitis E, and adenovirus. His final position in the military was as the Director of the U.S.

Military Infectious Diseases Research Program. Dr. Vaughn holds B.A. degrees in Chemistry and Psychology from Seattle Pacific University, an M.D. degree from St. Louis University School of Medicine, Pediatrics certification following training at Indiana University School of Medicine, and an M.P.H. from the Johns Hopkins University School of Public Health and Hygiene.